These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16009909)

  • 21. The paucity of genetic studies of alcohol phenotypes in diverse populations: what are the consequences and opportunities?
    Chartier KG
    Addiction; 2019 Jul; 114(7):1147-1149. PubMed ID: 30537438
    [No Abstract]   [Full Text] [Related]  

  • 22. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy.
    Greig NH; Lahiri DK; Sambamurti K
    Int Psychogeriatr; 2002; 14 Suppl 1():77-91. PubMed ID: 12636181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts.
    Clark LN; Levy G; Tang MX; Mejia-Santana H; Ciappa A; Tycko B; Cote LJ; Louis ED; Mayeux R; Marder K
    Neurosci Lett; 2003 Aug; 347(1):17-20. PubMed ID: 12865131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of donepezil in elderly patients with Alzheimer's disease--a Hawaii based study.
    Alagiakrishnan K; Wong W; Blanchette PL
    Hawaii Med J; 2000 Feb; 59(2):57-9. PubMed ID: 10800254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study.
    Poon I; Lal LS; Ford ME; Braun UK
    Ann Pharmacother; 2009 Feb; 43(2):185-93. PubMed ID: 19193586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic M(1) agonists in the treatment of Alzheimer's disease.
    Korczyn AD
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2259-67. PubMed ID: 11060805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
    Suh DC; Arcona S; Thomas SK; Powers C; Rabinowicz AL; Shin H; Mirski D
    Drugs Aging; 2004; 21(6):395-403. PubMed ID: 15084141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment.
    McClendon MJ; Hernandez S; Smyth KA; Lerner AJ
    J Alzheimers Dis; 2009; 16(3):577-83. PubMed ID: 19276552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association study of subclinical interstitial lung disease in MESA.
    Manichaikul A; Wang XQ; Sun L; Dupuis J; Borczuk AC; Nguyen JN; Raghu G; Hoffman EA; Onengut-Gumuscu S; Farber EA; Kaufman JD; Rabinowitz D; Stukovsky KDH; Kawut SM; Hunninghake GM; Washko GR; O'Connor GT; Rich SS; Barr RG; Lederer DJ
    Respir Res; 2017 May; 18(1):97. PubMed ID: 28521775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
    Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
    Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease.
    Venneri A; McGeown WJ; Shanks MF
    Neuroreport; 2005 Feb; 16(2):107-10. PubMed ID: 15671856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased inflammation in BA21 brain tissue from African Americans with Alzheimer's disease.
    Ferguson SA; Varma V; Sloper D; Panos JJ; Sarkar S
    Metab Brain Dis; 2020 Jan; 35(1):121-133. PubMed ID: 31823110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of dementia among white and African American relatives of patients with Alzheimer disease.
    Green RC; Cupples LA; Go R; Benke KS; Edeki T; Griffith PA; Williams M; Hipps Y; Graff-Radford N; Bachman D; Farrer LA;
    JAMA; 2002 Jan; 287(3):329-36. PubMed ID: 11790212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology.
    Uddin MS; Kabir MT; Rahman MM; Mathew B; Shah MA; Ashraf GM
    J Pharm Pharmacol; 2020 Aug; 72(8):1001-1012. PubMed ID: 32149402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study.
    Tamimi I; Ojea T; Sanchez-Siles JM; Rojas F; Martin I; Gormaz I; Perez A; Dawid-Milner MS; Mendez L; Tamimi F
    J Bone Miner Res; 2012 Jul; 27(7):1518-27. PubMed ID: 22467182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylcholinesterase in Alzheimer's disease.
    Talesa VN
    Mech Ageing Dev; 2001 Nov; 122(16):1961-9. PubMed ID: 11589914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease.
    Liston DR; Nielsen JA; Villalobos A; Chapin D; Jones SB; Hubbard ST; Shalaby IA; Ramirez A; Nason D; White WF
    Eur J Pharmacol; 2004 Feb; 486(1):9-17. PubMed ID: 14751402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Birth hospital and racial and ethnic differences in severe maternal morbidity in the state of California.
    Mujahid MS; Kan P; Leonard SA; Hailu EM; Wall-Wieler E; Abrams B; Main E; Profit J; Carmichael SL
    Am J Obstet Gynecol; 2021 Feb; 224(2):219.e1-219.e15. PubMed ID: 32798461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease.
    Venneri A; Lane R
    Neuroreport; 2009 Feb; 20(3):285-8. PubMed ID: 19444953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.